Follow
Abby Alpert
Abby Alpert
Assistant Professor, The Wharton School, University of Pennsylvania
Verified email at wharton.upenn.edu - Homepage
Title
Cited by
Cited by
Year
Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids
A Alpert, D Powell, RL Pacula
American Economic Journal: Economic Policy 10 (4), 1-35, 2018
3852018
Origins of the opioid crisis and its enduring impacts
A Alpert, WN Evans, EMJ Lieber, D Powell
The Quarterly Journal of Economics 137 (2), 1139-1179, 2022
1542022
The anticipatory effects of Medicare Part D on drug utilization
A Alpert
Journal of health economics 49, 28-45, 2016
872016
Giving EMS flexibility in transporting low-acuity patients could generate substantial Medicare savings
A Alpert, KG Morganti, GS Margolis, J Wasserman, AL Kellermann
Health Affairs 32 (12), 2142-2148, 2013
792013
A transitioning epidemic: how the opioid crisis is driving the rise in hepatitis C
D Powell, A Alpert, RL Pacula
Health Affairs 38 (2), 287-294, 2019
762019
Evaluating the role of payment policy in driving vertical integration in the oncology market
A Alpert, H Hsi, M Jacobson
Health Affairs 36 (4), 680-688, 2017
482017
Prescription drug advertising and drug utilization: The role of Medicare Part D
A Alpert, D Lakdawalla, N Sood
Journal of Public Economics 221, 104860, 2023
46*2023
Estimating intensive and extensive tax responsiveness
A Alpert, D Powell
Economic Inquiry 58 (4), 1855-1873, 2020
37*2020
Perverse reverse price competition: Average wholesale prices and Medicaid pharmaceutical spending
A Alpert, M Duggan, JK Hellerstein
Journal of Public Economics 108, 44-62, 2013
362013
How do prescription drug monitoring programs reduce opioid prescribing? the role of hassle costs versus information
AE Alpert, SE Dykstra, M Jacobson
National Bureau of Economic Research, 2020
322020
A socioeconomic profile of older adults with HIV
G Joyce, DP Goldman, AA Leibowitz, A Alpert, Y Bao
Journal of Health Care for the Poor and Underserved 16 (1), 19-28, 2005
322005
Should payment policy be changed to allow a wider range of EMS transport options?
KG Morganti, A Alpert, G Margolis, J Wasserman, AL Kellermann
Annals of Emergency Medicine 63 (5), 615-626. e5, 2014
242014
Impact of oncology drug shortages on chemotherapy treatment
A Alpert, M Jacobson
Clinical Pharmacology & Therapeutics 106 (2), 415-421, 2019
232019
Post-acute referral patterns for hospitals and implications for bundled payment initiatives
C Lau, A Alpert, P Huckfeldt, P Hussey, D Auerbach, H Liu, N Sood, ...
Healthcare 2 (3), 190-195, 2014
212014
The state of innovative emergency medical service programs in the United States
KG Morganti, A Alpert, G Margolis, J Wasserman, AL Kellermann
Prehospital Emergency Care 18 (1), 76-85, 2014
132014
Effects of payment reform in more versus less competitive markets
N Sood, A Alpert, K Barnes, P Huckfeldt, JJ Escarce
Journal of health economics 51, 66-83, 2017
112017
Prescription drug shortages: Reconsidering the role of Medicare payment policies
M Jacobson, A Alpert, F Duarte
Health Affairs Forefront, 2012
72012
Technology, monopoly, and the decline of the viatical settlements industry
N Sood, AE Alpert, J Bhattacharya
National Bureau of Economic Research, 2005
52005
How will provider-focused payment reform impact geographic variation in Medicare spending
D Auerbach, A Mehrotra, P Hussey, PJ Huckfeldt, A Alpert, C Lau, V Shier
Am J Manag Care 21 (6), e390-e398, 2015
32015
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market
C Gray, AE Alpert, N Sood
National Bureau of Economic Research, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20